Back to Trades
Happel David
InsiderCIK 0001623567
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Happel David accounts for 5 disclosed filings worth $4.7M, all concentrated in Sagimet Biosciences Inc. (SGMT), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $1.2M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 22 | SGMT Sagimet Biosciences Inc. | Happel David | Insider | Sell | $497.1K |
| Jun 1 | SGMT Sagimet Biosciences Inc. | Happel David | President & CEO, Director | Award | $2.2M |
| Feb 20 | SGMT Sagimet Biosciences Inc. | Happel David | President & CEO, Director | Grant | $1.4M |
| Feb 12 | SGMT Sagimet Biosciences Inc. | Happel David | President & CEO, Director | Sell | $64.9K |
| Jul 23 | SGMT Sagimet Biosciences Inc. | Happel David | President & CEO, Director | Sell | $598.1K |
5 filings